Empower your patients to become active stakeholders in their treatment
Patient-PDT engagement is considered a major factor in determining the success of future treatment, as it presupposes active patient participation.1
Discreet access to care anyplace, anytime
PDTs can help empower patients by enhancing insight into their condition, promoting engagement with their treatment, and encouraging adherence to healthy lifestyle behaviors and prescribed medications.2-6
Self-paced design to help promote disease education4,7
Self-directed training sessions and behavior-modifying activities2,6
Treatment reminders and individualized dosing calculations5
Aid goal setting and achievement with progress tracking4
Capture unique data for health information analysis3
Prescribed within the healthcare provider's office. Once downloaded, patients are guided through activation steps7
Components of cognitive behavioral therapy (CBT)—a proven treatment for mental health conditions—can be delivered by PDTs7,9
References
-
Wang C, Lee C, Shin H. Digital therapeutics from bench to bedside. NPJ Digit Med. 2023;6(1):38. doi:10.1038/s41746-023-00777-z
-
Liesch J, Murphy D. Digital Therapeutics 101: An Introduction and Overview. Blue Matter Consulting. Published 2021. Accessed May 17, 2024. https://bluematterconsulting.com/wp-content/uploads/2021/06/Digital-Therapeutics-101-eBook-06-2021.pdf
-
Dang A, Arora D, Rane P. Role of digital therapeutics and the changing future of healthcare. J Family Med Prim Care. 2020;9(5):2207-2213. doi:10.4103/jfmpc.jfmpc_105_20
-
Jacobson NC, Kowatch T, Marsch LA, eds. Digital Therapeutics for Mental Health and Addiction: The State of the Science and Vision for the Future. Academic Press; 2023.
-
Unnikrishnan AG, Viswanathan V, Zhou FL, et al. Impact of My Dose Coach app frequency of use on clinical outcomes in type 2 diabetes. Diabetes Ther. 2022;13(5):983-993. doi:10.1007/s13300-022-01245-9
-
EndeavorRx. Instructions for use. Akili Interactive Labs, Inc.; 2023.
-
Shafai G, Aungst TD. Prescription digital therapeutics: a new frontier for pharmacists and the future of treatment. J Am Pharm Assoc (2003). 2023;63(4):1030-1034. doi:10.1016/j.japh.2023.03.012
-
Lutz J, Offidani E, Taraboanta L, Lakhan SE, Campellone TR. Appropriate controls for digital therapeutic clinical trials: a narrative review of control conditions in clinical trials of digital therapeutics (DTx) deploying psychosocial, cognitive, or behavioral content. Front Digit Health. 2022;4:823977. doi:10.3389/fdgth.2022.823977
-
Hofmann SG, Asnaani A, Vonk IJ, Sawyer AT, Fang A. The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cognit Ther Res. 2012;36(5):427-440. doi: 10.1007/s10608-012-9476-1
-
American Psychological Association. Digital Mental Health Technologies. Accessed October 7, 2024. https://www.apa.org/practice/digital-therapeutics-mobile-health
-
Salsabili M, Tesell M, Alcusky M, et al. Prescription digital therapeutics: applying Medicaid experience to value assessment and formulary management. J Manag Care Spec Pharm. 2023;29(6):685-691. doi:10.18553/jmcp.2023.29.6.685
-
Brezing CA, Brixner DI. The rise of prescription digital therapeutics in behavioral health. Adv Ther. 2022;39(12):5301-5306. doi:10.1007/s12325-022-02320-0
-
Burrone V, Graham L, Bevan A. Digital therapeutics: past trends and future prospects. Evidera. Published Spring 2020. Accessed August 22, 2024. https://www.evidera.com/digital-therapeutics-past-trends-and-future-prospects/
-
Graff JS. Considerations for US coverage and reimbursement: which digital health products to evaluate? Findings from a modified Delphi study. J Manag Care Spec Pharm. 2024;30(8):854-859. doi:10.18553/jmcp.2024.30.8.854